{"id":"NCT01077362","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents","officialTitle":"A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Ustekinumab, a Fully Human Anti-IL-12/23p40 Monoclonal Antibody, Administered Subcutaneously, in Subjects With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti-TNFalpha Agent(s)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03","primaryCompletion":"2012-03","completion":"2012-11","firstPosted":"2010-03-01","resultsPosted":"2014-02-27","lastUpdate":"2014-02-27"},"enrollment":312,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Arthritis, Psoriatic"],"interventions":[{"type":"DRUG","name":"placebo","otherNames":[]},{"type":"DRUG","name":"ustekinumab 45 mg","otherNames":[]},{"type":"DRUG","name":"ustekinumab 90 mg","otherNames":[]}],"arms":[{"label":"Placebo","type":"EXPERIMENTAL"},{"label":"Ustekinumab 45 mg","type":"EXPERIMENTAL"},{"label":"Ustekinumab 90 mg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy (improvement of signs and symptoms) and safety of ustekinumab in patients with psoriatic arthritis.","primaryOutcome":{"measure":"Percentage of Participants With American College of Rheumatology (ACR) 20 Response at Week 24.","timeFrame":"Week 24","effectByArm":[{"arm":"Placebo","deltaMin":20.2,"sd":null},{"arm":"Ustekinumab 45 mg","deltaMin":43.7,"sd":null},{"arm":"Ustekinumab 90 mg","deltaMin":43.8,"sd":null},{"arm":"All Ustekinumab Combined","deltaMin":43.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG003","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":80,"countries":["United States","Austria","Canada","France","Germany","Hungary","Poland","Russia","Sweden","United Kingdom"]},"refs":{"pmids":["39120848","32209721","31070869","30739254","27483458","27098404"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":104},"commonTop":["Nasopharyngitis","Headache","Psoriatic Arthropathy","Bronchitis","Sinusitis"]}}